MOSTAFA GABER to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications MOSTAFA GABER has written about Xenograft Model Antitumor Assays.
Connection Strength
0.041
-
Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer. J Hepatol. 2016 08; 65(2):325-33.
Score: 0.025
-
IFN-beta restricts tumor growth and sensitizes alveolar rhabdomyosarcoma to ionizing radiation. Mol Cancer Ther. 2010 Mar; 9(3):761-71.
Score: 0.016